Navelbine (NVB), and fractionated dose doxorubicin (DX) improves first line advanced breast cancer (ABC) chemotherapy. An overview of 3 phase II trials

European Journal of Cancer ◽

10.1016/s0959-8049(97)85224-0 ◽

1997 ◽

Vol 33 ◽

pp. S146 ◽

Author(s):

J. Carmichael ◽

R. Hegg ◽

D. Firat ◽

M. Pawlicki ◽

F. Le Bras ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Phase Ii Trials ◽

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

Annals of Oncology ◽

10.1093/annonc/mdi056 ◽

2005 ◽

Vol 16 (2) ◽

pp. 253-258 ◽

Author(s):

L. Del Mastro ◽

F. Perrone ◽

L. Repetto ◽

L. Manzione ◽

V. Zagonel ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Line Chemotherapy

Download Full-text

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

10.1158/1538-7445.am2014-ct101 ◽

2014 ◽

Author(s):

Richard S. Finn ◽

John P. Crown ◽

Istvan Lang ◽

Katalin Boer ◽

Igor M. Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Cyclin Dependent Kinase ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Survival analysis from two open-label non-randomized phase II trials of trastuzumab (H) combined with docetaxel (T) and platinums (C, cisplatin or carboplatin) (TCH) in women with HER2+ advanced breast cancer (ABC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.642 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 642-642 ◽

Author(s):

D. Slamon ◽

C. H. Yeon ◽

T. Pienkowski ◽

D. Northfelt ◽

W. Eiermann ◽

...

Keyword(s):

Breast Cancer ◽

Survival Analysis ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Phase Ii Trials ◽

Randomized Phase Ii

Download Full-text

Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.761 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 761-761

Author(s):

S. Barni ◽

M. T. Ionta ◽

R. Labianca ◽

A. Zaniboni ◽

A. Ardizzoia ◽

...

Keyword(s):

Breast Cancer ◽

Multicentre Study ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Line Chemotherapy

Download Full-text

Vinorelbine (N)-capecitabine (C) combination in advanced breast cancer (ABC): Long-term results of two multicentric phase II trials

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.673 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 673-673 ◽

Author(s):

M. Ghosn ◽

G. Chahine ◽

J. Kattan ◽

F. Farhat ◽

F. Nasr ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Long Term Results ◽

Phase Ii Trials

Download Full-text

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC

British Journal of Cancer ◽

10.1038/bjc.1996.416 ◽

1996 ◽

Vol 74 (4) ◽

pp. 650-656 ◽

Author(s):

V Dieras ◽

◽

B Chevallier ◽

P Kerbrat ◽

I Krakowski ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Clinical Screening ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text

Activity and Safety of Vinorelbine Combined with Doxorubicin or Fluorouracil as First‐Line Therapy in Advanced Breast Cancer: A Stratified Phase II Study

The Oncologist ◽

10.1634/theoncologist.6-3-269 ◽

2001 ◽

Vol 6 (3) ◽

pp. 269-277 ◽

Author(s):

Howard S. Hochster ◽

Charles L. Vogel ◽

Susan L. Burman ◽

Robin White

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line Therapy ◽

Download Full-text

Phase II study of sequential administration of vinorelbine -capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.817 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 817-817 ◽

Author(s):

M. Ghosn ◽

G. Chahine ◽

J. Kattan ◽

F. Farhat ◽

F. Nasr ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Docetaxel ◽

Sequential Administration ◽

Line Chemotherapy

Download Full-text

Phase II study of sequential administration of vinorelbine -capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.817 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 817-817

Author(s):

M. Ghosn ◽

G. Chahine ◽

J. Kattan ◽

F. Farhat ◽

F. Nasr ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Docetaxel ◽

Sequential Administration ◽

Line Chemotherapy

Download Full-text